Pfizer's Oncology Research & Development (ORD) unit in La Jolla, California, is seeking a Senior Scientist (PhD) focused on translating basic discoveries in the field of cancer epigenetics into novel therapeutics.
The Senior Scientist will work within a collaborative team of motivated and scientifically rigorous scientists to conduct preclinical research and advance our clinical and pre-clinical drug programs in the field of cancer epigenetics. Our ideal candidate will have a strong background employing state-of-the art approaches to gain a broader understanding of epigenetic regulation in cancer biology. The candidate will translate basic research findings into therapeutic strategies, utilizing genetic and pharmacological approaches to understand target mechanism of action and generate patient stratification strategies. The successful candidate will demonstrate a proven track record of scientific productivity as evidenced by first author publications in scientific journals. Experience in the integration of molecular profiling data including epigenomic (ATAC-seq, ChIP-seq), transcriptomic, proteomic, and genomic datasets will be a plus.ROLE RESPONSIBILITIES
QUALIFICATIONS Basic Qualifications
- Utilize expertise in epigenetic biology to develop innovative strategies for understanding the role of epigenetic mechanisms in cancer progression, drug resistance and immune modulation
- Design, execute and analyze/interpret experiments to advance mechanism of action studies, develop patient responder hypotheses, elucidate mechanisms of resistance and identify rational drug combinations that can be translated to the clinic
- Work collaboratively with computational biology group to integrate complex data sets including epigenomic and other 'omic' data in pre-clinical settings for target validation and increased understanding of target biology
- Interface with discovery biology, discovery technologies and computational biology groups to design, develop, and interpret datasets developed from genetic and pharmacological screens
- Proactively seek out new information in the literature and incorporate this into individual project(s) as well as the overall program
- Present research results and methodologies at weekly meetings with immediate supervisor and/or project leader, project team meetings and other research forums
- Contribute to building a culture that embraces scientific excellence, urgency, partnerships with key stakeholders, continuous learning and improvement, increasing technical skill base and cancer biology expertise; take a proactive role in personal growth and scientific development.
- PhD or MD/PhD in Molecular or Cellular Biology, Genetics, Pharmacology (or a comparable biological science) with 4+ years of relevant postdoctoral experience in an academic or pharmaceutical/biotech environment.
- Expertise in chromatin biology, epigenetics and mechanism of transcriptional regulation as evidenced by publication in peer-reviewed journals.
- Preference for candidates with a strong track record in cancer drug discovery/translational research and the targeting of epigenetic pathways by small-molecule inhibitors.
- Expertise in techniques used for epigenetic/ transcriptional profiling including ChIP-seq, ATAC-seq, nascent and bulk RNA-seq
- Able to work in a team environment, good communication skills and excellent leaderships skills.
OTHER JOB DETAILS
- Proficiency in the use of bioinformatic software tools to support epigenomic data analysis including ATAC-seq, ChIP-seq, and RNA-seq.
- Extensive knowledge and understanding of other areas of tumor biology including but not limited to immuno-oncology, oncogenic signaling, cancer metabolism, apoptosis and/or DNA damage and repair
- Experience in use of CRISPR-based techniques for gene knockout, gene editing and as well as working knowledge of pooled CRISPR -based screening approaches
Eligible for Relocation Package
Eligible for Employee Referral BonusPfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative. EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.
Research and Development